Arf6 is frequently overexpressed in several types of cancer, including invasive breast cancer, melanoma and pancreatic cancer and Arf6 activity is driving these tumor cells to become more invasive [34, 40–45]. Here, ARF6 is linked to invasive breast carcinoma.